Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS · Delayed Price · Currency is USD
0.2578
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
Ampio Pharmaceuticals Market Cap
Ampio Pharmaceuticals has a market cap or net worth of $292.64 thousand as of January 23, 2026. Its market cap has decreased by -81.87% in one year.
Market Cap
292.64K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
Market Cap Chart
Since March 10, 2010, Ampio Pharmaceuticals's market cap has decreased from 34.12M to 292.64K, a decrease of -99.14%. That is a compound annual growth rate of -25.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 292.64K | 4,856.62% |
| Dec 30, 2025 | 5.90K | 100.00% |
| Dec 31, 2024 | 2.95K | -99.83% |
| Dec 29, 2023 | 1.71M | -49.79% |
| Dec 30, 2022 | 3.40M | -97.38% |
| Dec 31, 2021 | 129.46M | -56.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regenerative Medical Technology Group | 515.05K |
| Bio-Path Holdings | 502.77K |
| Helix BioMedix | 449.42K |
| Actavia Life Sciences | 385.91K |
| Innovation Pharmaceuticals | 370.14K |
| Oncology Pharma | 334.65K |
| Hemagen Diagnostics | 312.33K |
| CNBX Pharmaceuticals | 217.69K |